IL‐6 has also been reported to influence the tumor immune microenvironment by promoting the induction of suppressive immune cells, such as regulatory T cells (Tregs) and MDSCs, thereby facilitating cancer progression [33, 34]. The gene discussed is IL6; the disease is neoplasm.